As of 2026-10-31, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (324.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 85.00 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -481.9%.
The range of the Relative Valuation is (292.79) - (381.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 28.8x | 25.5x |
| Forward P/E multiples | 18.2x - 28.9x | 23.5x |
| Fair Price | (292.79) - (381.55) | (324.58) |
| Upside | -444.5% - -548.9% | -481.9% |
| Date | P/E |
| 2026-10-30 | -6.42 |
| 2026-10-29 | -6.52 |
| 2026-10-28 | -6.48 |
| 2026-10-27 | -6.46 |
| 2026-10-26 | -6.29 |
| 2026-10-23 | -6.07 |
| 2026-10-22 | -6.27 |
| 2026-10-21 | -6.30 |
| 2026-10-20 | -6.42 |
| 2026-10-19 | -6.21 |
| 2026-10-16 | -6.05 |
| 2026-10-15 | -6.22 |
| 2026-10-14 | -6.04 |
| 2026-10-13 | -6.01 |
| 2026-10-12 | -6.50 |
| 2026-10-09 | -6.49 |
| 2026-10-08 | -6.14 |
| 2026-10-07 | -6.09 |
| 2026-10-06 | -5.98 |
| 2026-10-05 | -6.15 |
| 2026-10-02 | -6.26 |
| 2026-10-01 | -6.33 |
| 2026-09-30 | -6.45 |
| 2026-09-29 | -6.61 |
| 2026-09-28 | -6.64 |
| 2026-09-25 | -6.77 |
| 2026-09-24 | -6.75 |
| 2026-09-23 | -6.74 |
| 2026-09-22 | -6.90 |
| 2026-09-21 | -6.94 |
| 2026-09-18 | -6.93 |
| 2026-09-17 | -7.46 |
| 2026-09-16 | -7.35 |
| 2026-09-15 | -7.09 |
| 2026-09-14 | -7.30 |
| 2026-09-11 | -7.41 |
| 2026-09-10 | -7.59 |
| 2026-09-09 | -7.42 |
| 2026-09-08 | -7.51 |
| 2026-09-04 | -7.62 |
| 2026-09-03 | -7.60 |
| 2026-09-02 | -7.54 |
| 2026-09-01 | -7.42 |
| 2026-08-31 | -7.40 |
| 2026-08-28 | -7.36 |
| 2026-08-27 | -7.53 |
| 2026-08-26 | -7.44 |
| 2026-08-25 | -7.40 |
| 2026-08-24 | -7.30 |
| 2026-08-21 | -7.27 |